| Robert C. Bast Jr. | |
| Birth Date: | 8 December 1943 |
| Workplaces: | University of Texas MD Anderson Cancer Center |
| Spouses: | )--> |
| Partners: | )--> |
Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is currently Vice President for Translational Research at the University of Texas M.D. Anderson Cancer Center.[1] Bast is best known for the discovery of CA125, a serum biomarker for ovarian cancer that has contributed to the care of ovarian cancer patients worldwide.[2] His research spans early detection, enhancing chemotherapy and understanding regulation of dormancy and the role of autophagy in breast and ovarian cancer.